GH Research PLC (GHRS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for GH Research PLC, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$20.71
+3.45% today
Market cap
$1.4B
Overall quality
—
Kronos AI 30-day
+19.9%
8 of 8 simulated paths end higher
GH Research PLC (GHRS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.4B. It trades at $20.71, up 3.45% today. 9 analysts' average target of $43.38 implies +109.5% from today's price. Kronos AI's 30-day forecast is +19.9% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $43.38 |
| Low – high | $38.00 – $65.00 |
| Analysts | 9 |
| Upside to average | +109.5% |
Kronos AI 30-day forecast
| Expected close | $24.01 (+19.9%) |
| Likely range | +16.1% … +33.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.